| 000 | 01558 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515135125.0 | ||
| 264 | 0 | _c20081112 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2008.07.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKiattisunthorn, K | |
| 245 | 0 | 0 |
_aEvaluating the clinical course and prognostic factors of posttransplantation immunoglobulin A nephropathy. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cSep 2008 |
||
| 300 |
_a2349-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aCadaver |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlomerulonephritis, IGA _xetiology |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aLiving Donors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProteinuria _xetiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 700 | 1 | _aPremasathian, N | |
| 700 | 1 | _aWongwiwatana, A | |
| 700 | 1 | _aParichatikanond, P | |
| 700 | 1 | _aCheunsuchon, B | |
| 700 | 1 | _aVasuvattakul, S | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 40 _gno. 7 _gp. 2349-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2008.07.008 _zAvailable from publisher's website |
| 999 |
_c18258850 _d18258850 |
||